Comprehensive screening of doping agents of various therapeutic categories in horse urine using solid phase extraction followed by liquid chromatography-tandem mass spectrometry.
Ahi S, Dubey S, Beotra A, Dubey S, Kaur T, Jain S.
Anal. Chem.: Ind. J., 2014, 14, 208–219.
An easy stereoselective synthesis of 5(10)-estrene-3β,17α-diol, a biological marker of pregnancy in the mare.
Balssa F, Fischer M, Bonnaire Y.
Steroids, 2014, 86, 1–4.
Scopolamine in racing horses: trace identifications associated with dietary or environmental exposure.
Brewer K, Dirikolu L, Hughes CG, Tobin T.
Vet. J., 2014, 199, 324–331.
Development and validation of a rapid and high-sensitivity liquid chromatography-tandem mass spectrometry assay for the determination of neostigmine in small-volume beagle dog plasma and its application to a pharmacokinetic study.
Cao D, Li W, Zhao X, Ye X, Sun F, Li J, Song F, Fan G.
Biomed. Chromatogr., 2014, 28, 354–361.
Identification of sample donor by 24-plex short tandem repeat in a post-race equine plasma containing dexamethasone.
Chen JW, Uboh CE, Soma LR, You Y, Jiang Z, Li X, Guan F, Liu Y.
Springerplus, 2014, 3, 94.
Quantitation of fluphenazine in equine serum following fluphenazine decanoate administration.
Costello S, Heffron B, Taddei L, Benoit M, Hurt L, Simpson L, Bishop J, Folker-Calderon D, Negrusz A.
J. Anal. Toxicol., 2014, 37, 594–599.
Naproxen in the horse: pharmacokinetics and side effects in the elderly.
Della Rocca G, Di Salvo A, Cagnardi P, Marchesi MC, Conti MB.
Res. Vet. Sci., 2014, 96, 147–152.
A pharmacokinetic/clinical approach to postulate a local action of intra-articular xylazine administration in the horse: a preliminary study.
Di Salvo A, Della Rocca G, Bazzica C, Giontella A, Cagnardi P, Nannarone S.
J. Vet. Pharmacol. Ther., 2014, 37, 464–471.
Synthesis, purification, and chemical characterization of 20-dihydro-6-methylprednisone, an isomeric metabolite of methylprednisolone in the horse, for use as an analytical standard.
Eisenberg R, Kudrimoti S, Hughes CG, Maylin GA, Tobin T.
Drug Test. Anal., 2014, 6, 303–307.
Pharmacokinetics and physiological effects of repeated oral administrations of tramadol in horses.
Guedes AGP, Knych HK, Soares JHN, Brosnan RJ.
J. Vet. Pharmacol. Ther., 2014, 37, 269–278.
Pharmacokinetic evaluation of oral dantrolene in the dog.
Haraschak JL, Langston VC, Wang R, Riggs C, Fellman C, Ross MK, Bulla C, Lunsford K, Mackin A, Archer T.
J. Vet. Pharmacol. Ther., 2014, 37, 286–294.
Quantification of several acidic drugs in equine serum using LC-MS-MS.
Heffron B, Taddei L, Benoit M, Negrusz A.
J. Anal. Toxicol., 2014, 37, 600–604.
Doping control analysis of filgrastim in equine plasma and its application to a co-administration study of filgrastim and recombinant human erythropoietin in the horse.
Ho EN, Kwok WH, Lau MY, Wong AS, Lam KK, Stewart BD, Wan TS.
J. Chromatogr. A, 2014, 1338, 92–101.
Pharmacokinetics and safety of firocoxib after oral administration of repeated consecutive doses to neonatal foals.
Hovanessian N, Davis JL, McKenzie HC, Hodgson JL, Hodgson DR, Crisman MV.
J. Vet. Pharmacol. Ther., 2014, 37, 243–251.
Pharmacokinetics and bone resorption evaluation of a novel Cathepsin K inhibitor (VEL-0230) in healthy adult horses.
Hussein H, Ishihara A, Menendez M, Bertone A.
J. Vet. Pharmacol. Ther., 2014, 37, 556–564.
Determination of pergolide in horse plasma by UPLC-MS/MS for pharmacokinetic applications.
Jacobson GA, Pirie A, Edwards S, Hughes KJ, Rendle DI, Davies NW.
J. Pharm. Biomed. Anal., 2014, 94, 54–57.
Monitoring the endogenous steroid profile disruption in urine and blood upon nandrolone administration: an efficient and innovative strategy to screen for nandrolone abuse in entire male horses.
Kaabia Z, Dervilly-Pinel G, Popot MA, Bailly-Chouriberry L, Plou P, Bonnaire Y, Le Bizec B.
Drug Test. Anal., 2014, 6, 376–388.
Disposition of methylprednisolone acetate in plasma, urine, and synovial fluid following intra-articular administration to exercised thoroughbred horses.
Knych HK, Harrison LM, Casbeer HC, McKemie DS.
J. Vet. Pharmacol. Ther., 2014, 37, 125–132.
Detection, pharmacokinetics and cardiac effects following administration of clenbuterol to exercised horses.
Knych HK, Mitchell MM, Steinmetz SJ, McKemie DS.
Equine Vet. J., 2014, 46, 380–385.
Detection and pharmacokinetics of three formulations of firocoxib following multiple administrations to horses.
Knych HK, Stanley SD, Arthur RM, Mitchell MM.
Equine Vet. J., 2014, 46, 734–738.
Preliminary pharmacokinetics of morphine and its major metabolites following intravenous administration of four doses to horses.
Knych HK, Steffey EP, McKemie DS.
J. Vet. Pharmacol. Ther., 2014, 37, 374–381.
Development and validation of a hydrophilic interaction liquid chromatography with tandem mass spectrometry method for the simultaneous detection and quantification of etilefrine and oxilofrine in equine blood plasma and urine.
Kong N, Yi R, Zhao S, Sandhu J, Lam G, Loganathan D, Morrissey B.
J. Sep. Sci., 2014, 37, 3015–3023.
Comparative pharmacokinetics of intravenous fentanyl and buprenorphine in healthy greyhound dogs.
KuKanich B, Allen P.
J. Vet. Pharmacol. Ther., 2014, 37, 595–597.
Identification of recombinant human relaxin-2 in equine plasma by liquid chromatography-high resolution mass spectrometry.
Kwok WH, Ho EN, Leung GN, Wong AS, Yue SK, Wan TS.
Drug Test. Anal., 2014, 5, 627–633.
Detection of myo-inositol tris pyrophosphate (ITPP) in equine following an administration of ITPP.
Lam G, Zhao S, Sandhu J, Yi R, Loganathan D, Morrissey B.
Drug Test. Anal., 2014, 6, 268–276.
Effect of body weight on the pharmacokinetics of flunixin meglumine in miniature horses and quarter horses.
Lee CD, Maxwell LK.
J. Vet. Pharmacol. Ther., 2014, 37, 35–42.
Determination and pharmacokinetic studies of arecoline in dog plasma by liquid chromatography-tandem mass spectrometry.
Li B, Zhou XZ, Li JY, Yang YJ, Niu JR, Wei XJ, Liu XW, Li JS, Zhang JY.
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2014, 969, 12–18.
Simultaneous quantitation of polygalaxanthone III and four ginsenosides by ultra-fast liquid chromatography with tandem mass spectrometry in rat and beagle dog plasma after oral administration of Kai-Xin-San: application to a comparative pharmacokinetic study.
Lv C, Li Q, Zhang X, He B, Xu H, Yin Y, Liu R, Liu J, Chen X, Bi K.
J. Sep. Sci., 2014, 37, 1103–1110.
Selective and simultaneous determination of NSAIDs in equine plasma by HPLC with molecularly imprinted solid-phase extraction.
Meucci V, Minunni M, Vanni M, Sgorbini M, Corazza M, Intorre L.
Bioanalysis, 2014, 6, 2147–2158.
Development and validation of fast and simple flow injection analysis-tandem mass spectrometry (FIA-MS/MS) for the determination of metformin in dog serum.
Michel D, Gaunt MC, Arnason T, El-Aneed A.
Asian J. Pharm. Biomed. Anal., 2014, 107, 229–235.
Determination of nifedipine in dog plasma by high-performance liquid chromatography with tandem mass spectrometric detection.
Pan X, Zhou S, Fu Q, Hu X, Wu J.
Biomed. Chromatogr., 2014, 28, 1036–1040.
HPLC/ESI-MSn method for non amino bisphosphonates: application to the detection of tiludronate in equine plasma.
Popot MA, Garcia P, Hubert C, Bolopion A, Bailly-Chouriberry L, Bonnaire Y, Thibaud D, Guyonnet J.
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2014, 958, 108–116.
The pharmacokinetics of methocarbamol and guaifenesin after single intravenous and multiple-dose oral administration of methocarbamol in the horse.
Rumpler MJ, Colahan P, Sams RA.
J. Vet. Pharmacol. Ther., 2014, 37, 25–34.
The pharmacokinetics of glycopyrrolate in standardbred horses.
Rumpler MJ, Colahan P, Sams RA.
J. Vet. Pharmacol. Ther., 2014, 37, 260–268.
Pharmacokinetics and pharmacodynamics of glycopyrrolate following a continuous-rate infusion in the horse.
Rumpler MJ, Kandala B, Vickroy TW, Hochhaus G, Sams RA.
J. Vet. Pharmacol. Ther., 2014, 37, 133–144.
Pharmacokinetics and pharmacodynamics of xylazine administered by the intravenous or intra-osseous route in adult horses.
Santonastaso1 A, Hardy J, Cohen N, Fajt V.
J. Vet. Pharmacol. Ther., 2014, 37, 565–570.
A high throughput screen for 17 dermorphin peptides in equine and human urine and equine plasma.
Steel R, Timms M, Levina V, Vine J.
Drug Test. Anal., 2014, 6, 909–921.
Evaluation of horse urine sample preparation methods for metabolomics using LC coupled to HRMS.
Stojiljkovic N, Paris A, Garcia P, Popot MA, Bonnaire Y, Tabet JC, Junot C.
Bioanalysis, 2014, 6, 785–803.
Factors influencing total carbon dioxide concentrations in plasma of thoroughbred and standardbred racehorses.
Sutton GJ, Cawley A, Murphy C, Lau ML, Hibbert DB.
Drug Test. Anal., 2014, 6, 936–943.
A high-throughput LC-MS/MS screen for GHRP in equine and human urine, featuring peptide derivatization for improved chromatography.
Timms M, Hall N, Levina V, Vine J, Steel R.
Drug Test. Anal., 2014, 6, 985–995.
Fast and sensitive analysis of dermorphin and HYP6-dermorphin in equine plasma using liquid chromatography tandem mass spectrometry.
Wang CC, Hartmann-Fischbach P, Krueger TR, Wells TL, Feineman AR, Compton JC.
Drug Test. Anal., 2014, 6, 342–349.
Pharmacokinetics and metabolism study of firocoxib in camels after intravenous administration by using high-resolution bench-top orbitrap mass spectrometry.
Wasfi IA, Saeed HM, Agha BA, Kamel AM, Al Biriki NA, Al Neaimi KM, Al Ali WA, Sultan SM.
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2014, 974, 17–23.
Quantitation of clevidipine in dog blood by liquid chromatography tandem mass spectrometry: application to a pharmacokinetic study.
Wei H, Gu Y, Liu Y, Chen Y, Liu C, Si D.
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2014, 971, 52–57.
Doping control analyses in horseracing: a clinician’s guide.
Wong JK, Wan TS.
Vet. J., 2014, 200, 8–16.
Detection of efaproxiral (RSR13) and its metabolites in equine by liquid chromatography tandem mass spectrometry.
Yi R, Sandhu J, Zhao S, Lam G, Loganathan D, Morrissey B.
J. Mass Spectrom., 2014, 49, 57–67.
Simultaneous determination and pharmacokinetic study of metformin and pioglitazone in dog plasma by LC-MS-MS.
Zhang X, Peng Y, Wan P, Yin L, Wang G, Sun J.
J. Chromatogr. Sci., 2014, 52, 52–58.
Pharmacokinetics and tissue distribution of clevidipine and its metabolite in dogs and rats.
Zhou Y, He XM, Li HQ, Ni Y, Xu MZ, Chen H, Li WY.
J. Huazhong Univ. Sci. Technolog. Med. Sci., 2014, 34, 856–860.
Simultaneous determination of clevidipine and its primary metabolite in dog plasma by liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study.
Zhou Y, Li H, He X, Jia M, Ni Y, Xu M, Chen H, Li W.
J. Pharm. Biomed. Anal., 2014, 100, 294–299.